ResMed Inc.'s (NASDAQ: RMD) chairman and chief executive officer, Michael J. Farrell, completed a paired option exercise and share sale on April 7, 2026, according to a Form 4 filing with the Securities and Exchange Commission.
On that date Farrell exercised options to acquire 4,991 shares of ResMed common stock at an exercise price of $146.34, for a total exercise cost of $730,382. The filing shows the same 4,991 shares were sold the same day for aggregate proceeds of approximately $1.12 million, with sale prices ranging from $222.5643 to $227.96 per share.
Following the transactions, Farrell is listed as directly owning 466,223 shares of ResMed common stock. The filing also notes an indirect ownership of 2,090 shares held through the Lisette and Michael Farrell Family Trust.
At the time of reporting, ResMed stock is trading at $228.70, which corresponds to a market capitalization of $33.15 billion.
Company results and analyst responses
ResMed reported fiscal second-quarter 2026 results that included earnings per share of $2.81, beating analyst forecasts of $2.73. Revenue for the quarter was reported at $1.4 billion, which met consensus expectations. The company recorded double-digit revenue and earnings growth as described by one investment bank.
Analyst reactions following the quarterly results were varied but generally constructive. One firm raised its price target to $314 from $311 and maintained an Outperform rating. Another raised its target to $302 from $299 and kept an Overweight rating, citing a solid revenue beat. Other firms maintained more cautious stances - one reiterated a Hold rating while noting an improvement in organic revenue growth to 8% in the second quarter, up from 7% in the prior quarter; another also maintained a Hold rating with a $265 price target.
Valuation commentary and dividend history
Separately, an analysis noted in market commentary suggested the stock is undervalued relative to its Fair Value. That commentary also referenced ResMed's track record of consecutive dividend increases, stating the company has raised its dividend for 14 straight years. The commentary indicated there are additional proprietary tips and deeper research available through subscription research resources.
Context and implications
The filings and company results together provide a picture of active insider liquidity occurring simultaneously with a quarterly performance that exceeded EPS estimates and matched revenue expectations. The combination of executive transactions, public financial results, and subsequent analyst updates gives investors multiple data points to consider when assessing the stock.
All transaction details are drawn from the Form 4 filing referenced above and the company-reported quarterly results and publicly disclosed analyst reactions.